The ever increasing need to accelerate time to market for new drugs places a burden on analytical labs in terms of sample volume and confidence in data required for decision making. Innovations in trapped ion mobility mass spectrometry and software give BioPharma scientists new tools to characterize biologic drugs with more speed and keep up with the pace of development. Mass spectrometry imaging is becoming an essential tool to understand diseases and determine drugs PK and metabolism which are essential to address the right tissue and evaluate toxicity early.
Poster 2019: Structural study of a PEGylated therapeutic protein by MALDI-ISD and ESI-QTOF
Poster 2019: Streamlining mAb characterization with a PASEF based disulfide analysis workflow
Poster 2019: Separation of Asp/IsoAsp Isobaric Peptides using Trapped Ion Mobility Spectrometry (TIMS)
Poster 2019: The benefit of peptide CCS value prediction and experimental determination
Poster 2019: A software platform for the quality control of synthetic oligonucleotides
Poster 2019: Predicting Lymph Node Metastasis in Endometrial Cancer by multi-modal mass spectrometry imaging
Poster 2019: Mass Spectrometric In-Depth Proteome Analysis of the Kidneys from Rat Model of Diabetic Nephropathy
Poster 2019: Metabolomics Characterization of Cell Culture Media by Ultrahigh Resolution LC-QTOF-MS Analysis
Poster 2019: Analysis of Histones from HEK293 Cells using a QTOF with Trapped Ion Mobility and PASEF Workflows
Poster 2018: Routine Analysis of Host Cell Proteins in Antibody Preparations using PASEF
Poster 2018: Application of PASEF MS/MS scans to monoclonal antibody peptide mapping
Poster 2018: A unified workflow for automatic mapping of disulfide bonds in protein therapeutics based on high resolution LC-QTOF
For Research Use Only. Not for use in clinical diagnostic procedures.